peptide sciences glp-1 Diagram of how glucagon-like pep | Stock Image PEPTIDE SCIENCES SEMAGLUTIDE 3MG at
Description
DOI: 10.1038/s44360-026-00108-y The authors report no outside funding
According to Holst this result was especially encouraging
Participants receiving 2.4 mg of Sema weekly, alongside lifestyle modifications, experienced an average 14.9% reduction in body weight over 68 weekssubstantially more than the placebo group
Qsymia is approved for chronic weight management, unlike phentermine monotherapy which has only short-term approval
